International Journal on Magnetic Particle Imaging IJMPI
Vol. 11 No. 1 Suppl 1 (2025): Int J Mag Part Imag
A novel MPI blood assay for calculating ultra-short half-lives of magnetic tracers
Main Article Content
Copyright (c) 2025 Marzieh Salimi, Shreyas Kuddannaya, Jeff Bulte

This work is licensed under a Creative Commons Attribution 4.0 International License.
Abstract
We present a magnetic particle imaging (MPI)-based blood assay that can be used to accurately calculate the blood half-life of magnetic nanoparticles (MNPs) without the need of labeling them. Dual-catheterized rats received 2.0 mg Fe of Synomag®-D70, Synomag®-D50, Resovist® and Feraheme® by femoral vein injection. The MPI signal of blood samples drawn from the femoral artery at various time points was then measured. Synomag®-D70 exhibited biexponential clearance with half-lives of 3.2 and 31.2 min, Synomag®-D50 a monoexponential clearance (t1/2=11.4 min), Resovist® a biexponential clearance (t1/2=2.4 and 10.8 min), and Feraheme® a biexponential clearance (t1/2=60.9 and 4.5 min). Our results showed that this MPI assay is a sensitive and specific method for calculating blood half-life of existing MNP formulations and those in the pipeline, with exquisite sensitivity for ultra-short half-lives.